_id
6919e4633c536f8df2318090
Ticker
APTA.LSE
Name
Aptamer Group PLC
Exchange
LSE
Address
Windmill House, York, United Kingdom, YO10 5BR
Country
UK
Sector
Healthcare
Industry
Biotechnology
Currency
GBX
Website
https://aptamergroup.com
Description
Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and bioprocessing companies. It has collaborations with Unilever, Neuro-Bio, the University of Glasgow, AstraZeneca, and Invizius. Aptamer Group PLC was founded in 2008 and is headquartered in York, the United Kingdom.
Last Close
10750
Volume
12417146
Current Price
1.01
Change
-5.116279069767436
Last Updated
2025-12-29T14:59:17.477Z
Image
https://logo.clearbit.com/aptamergroup.com
Ipo Date
-
Market Cap
27644030
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
550000
Cost Of Revenue
452000
Gross Profit
98000
Operating Expenses
1534000
Operating Income
-1436000
Interest Expense
26000
Pretax Income
-1369000
Net Income
-1312000
Eps
-0.000658851834896535
Dividends Per Share
-
Shares Outstanding
2696978377
Income Tax Expense
-57000
EBITDA
-1229000
Operating Margin
-261.09090909090907
Total Other Income Expense Net
67000
Cash
1059000
Short Term Investments
-
Receivables
532000
Inventories
80000
Total Current Assets
1822000
Property Plant Equipment
414000
Total Assets
2834000
Payables
414000
Short Term Debt
249000
Long Term Debt
0
Total Liabilities
1452000
Equity
1382000
Bs_currency_symbol
GBP
Depreciation
114000
Change In Working Capital
178000
Cash From Operations
-682000
Capital Expenditures
4000
Cash From Investing
-58000
Cash From Financing
-168000
Net Change In Cash
-908000
Cf_currency_symbol
-
PE
-
PB
1455.3230435311143
ROE
-94.93487698986975
ROA
-46.29498941425547
FCF
-686000
Fcf Percent
-1.2472727272727273
Piotroski FScore
1
Health Score
17
Deep Value Investing Score
2
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
3
Net Net Investing Score
1
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
550000
Quarters > 0 > income Statement > cost Of Revenue
452000
Quarters > 0 > income Statement > gross Profit
98000
Quarters > 0 > income Statement > operating Expenses
1534000
Quarters > 0 > income Statement > operating Income
-1436000
Quarters > 0 > income Statement > interest Expense
26000
Quarters > 0 > income Statement > pretax Income
-1369000
Quarters > 0 > income Statement > net Income
-1312000
Quarters > 0 > income Statement > eps
-0.000658851834896535
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1991343016
Quarters > 0 > income Statement > income Tax Expense
-57000
Quarters > 0 > income Statement > EBITDA
-1229000
Quarters > 0 > income Statement > operating Margin
-261.09090909090907
Quarters > 0 > income Statement > total Other Income Expense Net
67000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
1059000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
532000
Quarters > 0 > balance Sheet > inventories
80000
Quarters > 0 > balance Sheet > total Current Assets
1822000
Quarters > 0 > balance Sheet > property Plant Equipment
414000
Quarters > 0 > balance Sheet > total Assets
2834000
Quarters > 0 > balance Sheet > payables
414000
Quarters > 0 > balance Sheet > short Term Debt
249000
Quarters > 0 > balance Sheet > long Term Debt
0
Quarters > 0 > balance Sheet > total Liabilities
1452000
Quarters > 0 > balance Sheet > equity
1382000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-1312000
Quarters > 0 > cash Flow > depreciation
114000
Quarters > 0 > cash Flow > change In Working Capital
178000
Quarters > 0 > cash Flow > cash From Operations
-682000
Quarters > 0 > cash Flow > capital Expenditures
4000
Quarters > 0 > cash Flow > cash From Investing
-58000
Quarters > 0 > cash Flow > cash From Financing
-168000
Quarters > 0 > cash Flow > net Change In Cash
-908000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.000658851834896535
Quarters > 0 > ratios > PB
1455.3230435311143
Quarters > 0 > ratios > ROE
-94.93487698986975
Quarters > 0 > ratios > ROA
-46.29498941425547
Quarters > 0 > ratios > FCF
-686000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.2472727272727273
Quarters > 0 > health Score
17
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
653000
Quarters > 1 > income Statement > cost Of Revenue
286000
Quarters > 1 > income Statement > gross Profit
367000
Quarters > 1 > income Statement > operating Expenses
1549000
Quarters > 1 > income Statement > operating Income
-1182000
Quarters > 1 > income Statement > interest Expense
31000
Quarters > 1 > income Statement > pretax Income
-1200000
Quarters > 1 > income Statement > net Income
-1112000
Quarters > 1 > income Statement > eps
-0.0026788236372874146
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
415107581
Quarters > 1 > income Statement > income Tax Expense
-88000
Quarters > 1 > income Statement > EBITDA
-1099000
Quarters > 1 > income Statement > operating Margin
-181.01071975497703
Quarters > 1 > income Statement > total Other Income Expense Net
-18000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
1967000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
657000
Quarters > 1 > balance Sheet > inventories
107000
Quarters > 1 > balance Sheet > total Current Assets
3278000
Quarters > 1 > balance Sheet > property Plant Equipment
512000
Quarters > 1 > balance Sheet > total Assets
4346000
Quarters > 1 > balance Sheet > payables
466000
Quarters > 1 > balance Sheet > short Term Debt
238000
Quarters > 1 > balance Sheet > long Term Debt
4000
Quarters > 1 > balance Sheet > total Liabilities
1784000
Quarters > 1 > balance Sheet > equity
2562000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
-1112000
Quarters > 1 > cash Flow > depreciation
115000
Quarters > 1 > cash Flow > change In Working Capital
-413000
Quarters > 1 > cash Flow > cash From Operations
-1319000
Quarters > 1 > cash Flow > capital Expenditures
6000
Quarters > 1 > cash Flow > cash From Investing
-34000
Quarters > 1 > cash Flow > cash From Financing
2450000
Quarters > 1 > cash Flow > net Change In Cash
1097000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.0026788236372874146
Quarters > 1 > ratios > PB
163.64506510928962
Quarters > 1 > ratios > ROE
-43.403590944574546
Quarters > 1 > ratios > ROA
-25.58674643350207
Quarters > 1 > ratios > FCF
-1325000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-2.029096477794793
Quarters > 1 > health Score
22
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
562000
Quarters > 2 > income Statement > cost Of Revenue
419000
Quarters > 2 > income Statement > gross Profit
143000
Quarters > 2 > income Statement > operating Expenses
1480000
Quarters > 2 > income Statement > operating Income
-1337000
Quarters > 2 > income Statement > interest Expense
39000
Quarters > 2 > income Statement > pretax Income
-1238000
Quarters > 2 > income Statement > net Income
-1151000
Quarters > 2 > income Statement > eps
-0.0027727751857174587
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
415107581
Quarters > 2 > income Statement > income Tax Expense
-87000
Quarters > 2 > income Statement > EBITDA
-1066000
Quarters > 2 > income Statement > operating Margin
-237.90035587188615
Quarters > 2 > income Statement > total Other Income Expense Net
99000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
870000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
469000
Quarters > 2 > balance Sheet > inventories
119000
Quarters > 2 > balance Sheet > total Current Assets
1620000
Quarters > 2 > balance Sheet > property Plant Equipment
611000
Quarters > 2 > balance Sheet > total Assets
2769000
Quarters > 2 > balance Sheet > payables
452000
Quarters > 2 > balance Sheet > short Term Debt
253000
Quarters > 2 > balance Sheet > long Term Debt
9000
Quarters > 2 > balance Sheet > total Liabilities
1882000
Quarters > 2 > balance Sheet > equity
887000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-1151000
Quarters > 2 > cash Flow > depreciation
133000
Quarters > 2 > cash Flow > change In Working Capital
27000
Quarters > 2 > cash Flow > cash From Operations
-566000
Quarters > 2 > cash Flow > capital Expenditures
8000
Quarters > 2 > cash Flow > cash From Investing
-82000
Quarters > 2 > cash Flow > cash From Financing
-238000
Quarters > 2 > cash Flow > net Change In Cash
-886000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0027727751857174587
Quarters > 2 > ratios > PB
472.67041354002254
Quarters > 2 > ratios > ROE
-129.7632468996618
Quarters > 2 > ratios > ROA
-41.56735283495847
Quarters > 2 > ratios > FCF
-574000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.0213523131672597
Quarters > 2 > health Score
13
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
298000
Quarters > 3 > income Statement > cost Of Revenue
324000
Quarters > 3 > income Statement > gross Profit
-26000
Quarters > 3 > income Statement > operating Expenses
1846000
Quarters > 3 > income Statement > operating Income
-1872000
Quarters > 3 > income Statement > interest Expense
84000
Quarters > 3 > income Statement > pretax Income
-1903000
Quarters > 3 > income Statement > net Income
-1807000
Quarters > 3 > income Statement > eps
-0.005028687997129256
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
359338261
Quarters > 3 > income Statement > income Tax Expense
-96000
Quarters > 3 > income Statement > EBITDA
-1749000
Quarters > 3 > income Statement > operating Margin
-628.1879194630873
Quarters > 3 > income Statement > total Other Income Expense Net
-31000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
1756000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
711000
Quarters > 3 > balance Sheet > inventories
132000
Quarters > 3 > balance Sheet > total Current Assets
2769000
Quarters > 3 > balance Sheet > property Plant Equipment
727000
Quarters > 3 > balance Sheet > total Assets
3968000
Quarters > 3 > balance Sheet > payables
287000
Quarters > 3 > balance Sheet > short Term Debt
412000
Quarters > 3 > balance Sheet > long Term Debt
14000
Quarters > 3 > balance Sheet > total Liabilities
1978000
Quarters > 3 > balance Sheet > equity
1990000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
-1807000
Quarters > 3 > cash Flow > depreciation
112000
Quarters > 3 > cash Flow > change In Working Capital
-9000
Quarters > 3 > cash Flow > cash From Operations
-1799000
Quarters > 3 > cash Flow > capital Expenditures
6000
Quarters > 3 > cash Flow > cash From Investing
-40000
Quarters > 3 > cash Flow > cash From Financing
3361000
Quarters > 3 > cash Flow > net Change In Cash
1522000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.005028687997129256
Quarters > 3 > ratios > PB
182.37771035678392
Quarters > 3 > ratios > ROE
-90.80402010050251
Quarters > 3 > ratios > ROA
-45.53931451612903
Quarters > 3 > ratios > FCF
-1805000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-6.057046979865772
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
1203000
Annuals > 0 > income Statement > cost Of Revenue
853000
Annuals > 0 > income Statement > gross Profit
350000
Annuals > 0 > income Statement > operating Expenses
3047000
Annuals > 0 > income Statement > operating Income
-2697000
Annuals > 0 > income Statement > interest Expense
57000
Annuals > 0 > income Statement > pretax Income
-2569000
Annuals > 0 > income Statement > net Income
-2424000
Annuals > 0 > income Statement > eps
-0.0013513761645511974
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1793727064
Annuals > 0 > income Statement > income Tax Expense
-145000
Annuals > 0 > income Statement > EBITDA
-2284000
Annuals > 0 > income Statement > operating Margin
-224.18952618453866
Annuals > 0 > income Statement > total Other Income Expense Net
128000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
1059000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
532000
Annuals > 0 > balance Sheet > inventories
80000
Annuals > 0 > balance Sheet > total Current Assets
1822000
Annuals > 0 > balance Sheet > property Plant Equipment
414000
Annuals > 0 > balance Sheet > total Assets
2834000
Annuals > 0 > balance Sheet > payables
414000
Annuals > 0 > balance Sheet > short Term Debt
249000
Annuals > 0 > balance Sheet > long Term Debt
0
Annuals > 0 > balance Sheet > total Liabilities
1452000
Annuals > 0 > balance Sheet > equity
1382000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-2424000
Annuals > 0 > cash Flow > depreciation
229000
Annuals > 0 > cash Flow > change In Working Capital
-161000
Annuals > 0 > cash Flow > cash From Operations
-2001000
Annuals > 0 > cash Flow > capital Expenditures
10000
Annuals > 0 > cash Flow > cash From Investing
-92000
Annuals > 0 > cash Flow > cash From Financing
2282000
Annuals > 0 > cash Flow > net Change In Cash
189000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.0013513761645511974
Annuals > 0 > ratios > PB
1406.1678011125903
Annuals > 0 > ratios > ROE
-175.39797395079594
Annuals > 0 > ratios > ROA
-85.53281580804517
Annuals > 0 > ratios > FCF
-2011000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.6716541978387365
Annuals > 0 > health Score
16
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
860000
Annuals > 1 > income Statement > cost Of Revenue
610000
Annuals > 1 > income Statement > gross Profit
250000
Annuals > 1 > income Statement > operating Expenses
3334000
Annuals > 1 > income Statement > operating Income
-3084000
Annuals > 1 > income Statement > interest Expense
81000
Annuals > 1 > income Statement > pretax Income
-3141000
Annuals > 1 > income Statement > net Income
-2958000
Annuals > 1 > income Statement > eps
-0.007125863596309507
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
415107581
Annuals > 1 > income Statement > income Tax Expense
-183000
Annuals > 1 > income Statement > EBITDA
-2815000
Annuals > 1 > income Statement > operating Margin
-358.6046511627907
Annuals > 1 > income Statement > total Other Income Expense Net
-57000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
870000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
277000
Annuals > 1 > balance Sheet > inventories
119000
Annuals > 1 > balance Sheet > total Current Assets
1620000
Annuals > 1 > balance Sheet > property Plant Equipment
611000
Annuals > 1 > balance Sheet > total Assets
2769000
Annuals > 1 > balance Sheet > payables
452000
Annuals > 1 > balance Sheet > short Term Debt
253000
Annuals > 1 > balance Sheet > long Term Debt
9000
Annuals > 1 > balance Sheet > total Liabilities
1882000
Annuals > 1 > balance Sheet > equity
887000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-2958000
Annuals > 1 > cash Flow > depreciation
245000
Annuals > 1 > cash Flow > change In Working Capital
18000
Annuals > 1 > cash Flow > cash From Operations
-2284000
Annuals > 1 > cash Flow > capital Expenditures
122000
Annuals > 1 > cash Flow > cash From Investing
-122000
Annuals > 1 > cash Flow > cash From Financing
3042000
Annuals > 1 > cash Flow > net Change In Cash
636000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.007125863596309507
Annuals > 1 > ratios > PB
507.0209168606538
Annuals > 1 > ratios > ROE
-333.4836527621195
Annuals > 1 > ratios > ROA
-106.82556879739977
Annuals > 1 > ratios > FCF
-2406000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.797674418604651
Annuals > 1 > health Score
12
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
1752000
Annuals > 2 > income Statement > cost Of Revenue
1393000
Annuals > 2 > income Statement > gross Profit
359000
Annuals > 2 > income Statement > operating Expenses
8516000
Annuals > 2 > income Statement > operating Income
-8157000
Annuals > 2 > income Statement > interest Expense
134000
Annuals > 2 > income Statement > pretax Income
-8298000
Annuals > 2 > income Statement > net Income
-7836000
Annuals > 2 > income Statement > eps
-0.11347416013373268
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
69055369
Annuals > 2 > income Statement > income Tax Expense
-462000
Annuals > 2 > income Statement > EBITDA
-7364000
Annuals > 2 > income Statement > operating Margin
-465.5821917808219
Annuals > 2 > income Statement > total Other Income Expense Net
-141000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
234000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
501000
Annuals > 2 > balance Sheet > inventories
204000
Annuals > 2 > balance Sheet > total Current Assets
1589000
Annuals > 2 > balance Sheet > property Plant Equipment
721000
Annuals > 2 > balance Sheet > total Assets
2753000
Annuals > 2 > balance Sheet > payables
656000
Annuals > 2 > balance Sheet > short Term Debt
314000
Annuals > 2 > balance Sheet > long Term Debt
19000
Annuals > 2 > balance Sheet > total Liabilities
2449000
Annuals > 2 > balance Sheet > equity
304000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-7836000
Annuals > 2 > cash Flow > depreciation
800000
Annuals > 2 > cash Flow > change In Working Capital
74000
Annuals > 2 > cash Flow > cash From Operations
-4064000
Annuals > 2 > cash Flow > capital Expenditures
2028000
Annuals > 2 > cash Flow > cash From Investing
-2028000
Annuals > 2 > cash Flow > cash From Financing
-365000
Annuals > 2 > cash Flow > net Change In Cash
-6457000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.11347416013373268
Annuals > 2 > ratios > PB
246.10061439013157
Annuals > 2 > ratios > ROE
-2577.6315789473683
Annuals > 2 > ratios > ROA
-284.63494369778425
Annuals > 2 > ratios > FCF
-6092000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-3.4771689497716896
Annuals > 2 > health Score
8
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
4036000
Annuals > 3 > income Statement > cost Of Revenue
1351000
Annuals > 3 > income Statement > gross Profit
2685000
Annuals > 3 > income Statement > operating Expenses
5261000
Annuals > 3 > income Statement > operating Income
-2576000
Annuals > 3 > income Statement > interest Expense
46000
Annuals > 3 > income Statement > pretax Income
-2638000
Annuals > 3 > income Statement > net Income
-2093000
Annuals > 3 > income Statement > eps
-0.0303234039566812
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
69022594
Annuals > 3 > income Statement > income Tax Expense
-545000
Annuals > 3 > income Statement > EBITDA
-2195000
Annuals > 3 > income Statement > operating Margin
-63.82556987115956
Annuals > 3 > income Statement > total Other Income Expense Net
-62000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
6691000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1699000
Annuals > 3 > balance Sheet > inventories
420000
Annuals > 3 > balance Sheet > total Current Assets
8977000
Annuals > 3 > balance Sheet > property Plant Equipment
1823000
Annuals > 3 > balance Sheet > total Assets
11520000
Annuals > 3 > balance Sheet > payables
514000
Annuals > 3 > balance Sheet > short Term Debt
248000
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
3469000
Annuals > 3 > balance Sheet > equity
8051000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-2093000
Annuals > 3 > cash Flow > depreciation
454000
Annuals > 3 > cash Flow > change In Working Capital
-1318000
Annuals > 3 > cash Flow > cash From Operations
-2375000
Annuals > 3 > cash Flow > capital Expenditures
418000
Annuals > 3 > cash Flow > cash From Investing
-418000
Annuals > 3 > cash Flow > cash From Financing
9115000
Annuals > 3 > cash Flow > net Change In Cash
6322000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-0.0303234039566812
Annuals > 3 > ratios > PB
9.288172691541423
Annuals > 3 > ratios > ROE
-25.99677058750466
Annuals > 3 > ratios > ROA
-18.16840277777778
Annuals > 3 > ratios > FCF
-2793000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.692021803766105
Annuals > 3 > health Score
27
Valuation > metrics > PE
-0.000658851834896535
Valuation > metrics > PB
1455.3230435311143
Valuation > final Score
20
Valuation > verdict
48410.8% Overvalued
Profitability > metrics > ROE
-94.93487698986975
Profitability > metrics > ROA
-72.00878155872668
Profitability > metrics > Net Margin
-2.3854545454545453
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.0506512301013025
Risk > metrics > Interest Coverage
-55.23076923076923
Risk > final Score
-191
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.7481146304675717
Liquidity > metrics > Quick Ratio
2.627450980392157
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-105
Prev Risks > 1
-119
Prev Risks > 2
-41
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:59:47.364Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-09
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-12-31
Earnings History > 1 > report Date
2025-03-11
Earnings History > 1 > date
2024-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-12-31
Earnings History > 2 > report Date
2023-03-14
Earnings History > 2 > date
2022-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
GBP
Earnings History > 2 > eps Actual
-0.04
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.04
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-09-30
Earnings History > 3 > report Date
2022-10-18
Earnings History > 3 > date
2022-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
-0.01
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.01
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-12-31
Earnings History > 4 > report Date
2022-03-31
Earnings History > 4 > date
2021-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-0.02
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.02
Earnings History > 4 > surprise Percent
-
Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and bioprocessing companies. It has collaborations with Unilever, Neuro-Bio, the University of Glasgow, AstraZeneca, and Invizius. Aptamer Group PLC was founded in 2008 and is headquartered in York, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Aptamer Group PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2024-12-31
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.